PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

PET scans offer insight into how ketamine affects depression
Thanks to a newly developed radiotracer and PET imaging, experts believe they may have unearthed new insights on the drug's impact.
Combining PET and MRI data may be key to differentiating new type of dementia
Limbic-predominant age-related TDP-43 encephalopathy, also known as LATE, was recently recognized as a type of dementia that occurs in older adults. It typically presents as memory-related cognitive decline.
Side effect of popular Alzheimer's treatment may actually be a good sign, new PET findings suggest
Amyloid-related imaging abnormality edema is a known side effect of anti-amyloid monoclonal antibody treatments, such as Leqembi and donanemab Kisunla.
Drugmaker expands manufacturing of popular prostate PET imaging agent
The move will make the Huntsman Cancer Institute the first academic medical center in the U.S. to produce Posluma, according to Blue Earth Diagnostics.
FDA clears new PET/MRI combo system from Siemens Healthineers
The Biograph One is the company's second-generation PET/MRI combo scanner—its first in 14 years.

Total-body PET scanner detects cancer in 60 seconds

The new equipment, which initially will be used to treat prostate and neuroendocrine tumors, is expected to be operational in July.

3 indications auguring well for the future of pediatric PET/MRI

In pediatric care settings, hybrid PET/MR imaging combines “exquisite soft-tissue information obtained by MR imaging with functional information provided by PET.”

FDA clears spinal-tap test that could challenge PET in Alzheimer’s diagnostics

The FDA has approved a lab test for evaluating cognitively impaired adults who may be in the early stages of Alzheimer’s disease.

CMS coverage decision for Alzheimer's drug, related PET scans sparks concern in imaging community

In a statement released on April 14, MITA cautioned that the coverage decision will “severely limit patient access” to amyloid PET diagnostics and anti-amyloid monoclonal antibodies treatment.

coronavirus COVID-19 vaccine vaccination

FDG PET/CT radiomics distinguishes between vaccine-related or metastatic breast cancer lymphadenopathy

The findings could help clinicians manage patients’ treatment when the origin of axillary lymphadenopathy is of concern, experts suggested.

Combination therapy that includes new radionuclide proves effective for metastatic prostate cancer

The therapeutic combination of 177Lu-PSMA-617 with idronoxil (NOX66) reduced PSA levels in 86% of study participants.

MRI/PET scans link brainstem atrophy to dementia symptoms

Experts suggest that their findings could help differentiate between dementia and other neurological diseases that have similar symptoms.

New radiotracer that detects prostate cancer recurrence produces 'stunning' results

The research focused on a radiopharmaceutical that contains the isotope zirconium 89, which has a significantly longer half-life compared to gallium-68-labelled PSMA ligands.

PET/CT

PET scans offer insight into how ketamine affects depression

Combining PET and MRI data may be key to differentiating new type of dementia

Side effect of popular Alzheimer's treatment may actually be a good sign, new PET findings suggest

Drugmaker expands manufacturing of popular prostate PET imaging agent

FDA clears new PET/MRI combo system from Siemens Healthineers